SCHEMBL21200767

SCHEMBL21200767

COC(=O)c1cc(N2CCN(C)CC2)nc(C2CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ CHRM3 P20309 4/20 0.44
▸ PDE4A P27815 4/20 0.44
▸ PDE4B Q07343 4/20 0.44
▸ PDE4C Q08493 4/20 0.44
▸ PDE4D Q08499 4/20 0.44
▸ TRPV4 Q9HBA0 2/20 0.42
▸ HRH4 Q9H3N8 3/20 0.40
▸ NAPEPLD Q6IQ20 1/20 0.40
▸ RBP4 P02753 1/20 0.39
▸ EHMT2 Q96KQ7 1/20 0.39
▸ P2RX3 P56373 1/20 0.39
▸ AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29867435 1.00 KDM4E (0.48) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL21200544 0.85 CHRM3 (0.48) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL29866760 0.85 CHRM3 (0.48) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL27440962 0.80 HRH4 (0.52) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL29867073 0.80 RBP4 (0.36) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL21199845 0.79 RBP4 (0.36) KDM4EALDH1A1CHRM3PDE4APDE4B
SCHEMBL21211937 0.78 CHRM3 (0.54) KMT2ACHRM3PDE4APDE4BPDE4C
SCHEMBL2133583 0.77 KDM4E (0.51) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL1506185 0.77 KDM4E (0.51) KDM4EKMT2AMEN1USP2ALDH1A1
SCHEMBL21200772 0.76 RBP4 (0.46) KDM4EKMT2AMEN1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback